Poly-N-Acetyl glucosamine nanofibers: A new bioactive material to enhance diabetic wound healing by cell migration and angiogenesis

Annals of Surgery

Volumn 250, Issue 2, 2009, Pages 322-330

  Scherer, Saja Sandra ^a   Pietramaggiori, Giorgio ^a   Matthews, Jasmine ^a   Perry, Samuel ^b   Assmann, Anke ^c   Carothers, Adelaide ^a   Demcheva, Marina ^d   Muise Helmericks, Robin C ^e   Seth, Arun ^f   Vournakis, John N ^d   Valeri, Robert C ^g   Fischer, Thomas H ^h   Hechtman, Herbert B ^b   Orgill, Dennis P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Marine Polymer Technologies Inc   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g Nav Blood Res Lab   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; GELATINASE B; INTERLEUKIN 1BETA; KI 67 ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYLGLUCOSAMINE; NANOFIBER; OXIDIZED REGENERATED CELLULOSE; PROTEIN P63; STROMELYSIN; TISSUE SCAFFOLD; VASCULOTROPIN; POLY N ACETYL GLUCOSAMINE; POLY-N-ACETYL GLUCOSAMINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL METABOLISM; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENDOTHELIUM CELL; EPITHELIZATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; GRANULATION TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; KERATINOCYTE; MALE; MARKER GENE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; TISSUE GROWTH; TISSUE REGENERATION; UPREGULATION; VASCULARIZATION; WOUND; WOUND CLOSURE; WOUND CONTRACTION; WOUND HEALING; ANIMAL; BIODEGRADABLE IMPLANT; C57BL MOUSE; CELL MOTION; CULTURE TECHNIQUE; DISEASE MODEL; DRUG EFFECT; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN ULCER;

ABSORBABLE IMPLANTS; ACETYLGLUCOSAMINE; ANIMALS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; DIABETES COMPLICATIONS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN ULCER; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 68949121107     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181ae9d45     Document Type: Article

References (22)

1. Complications of Diabetes in the United States. Available at: http://www. idf.org/home/index.cfm.
2. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382-387.
3. Winters B. Promoting wound healing in the diabetic patient. AORN J. 1982;35:1083-1087.
4. Lerman OZ, Galiano RD, Armour M, et al. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol. 2003;162:303-312.
5. Shoji T, Koyama H, Morioka T, et al. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes. 2006;55:2245-2255.
6. Facchiano F, Lentini A, Fogliano V, et al. Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo. Am J Pathol. 2002;161:531-541.
7. Loomans CJ, de Koning EJ, Staal FJ, et al. Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes. 2004;53:195-199.
8. Terashi H, Izumi K, Deveci M, et al. High glucose inhibits human epidermal keratinocyte proliferation for cellular studies on diabetes mellitus. Int Wound J. 2005;2:298-304.
9. Chan RK, Liu PH, Pietramaggiori G, et al. Effect of recombinant platelet-derived growth factor (Regranex) on wound closure in genetically diabetic mice. J Burn Care Res. 2006;27:202-205.
10. Fischer TH, Thatte HS, Nichols TC, et al. Synergistic platelet integrin signaling and factor XII activation in poly-N-acetyl glucosamine fiber-mediated hemostasis. Biomaterials. 2005;26:5433-5443.
11. Thatte HS, Zagarins S, Khuri SF, et al. Mechanisms of poly-N-acetyl glucosamine polymer-mediated hemostasis: platelet interactions. J Trauma. 2004;57(suppl 1):S13-S21.
12. Thatte HS, Zagarins SE, Amiji M, et al. Poly-N-acetyl glucosamine-mediated red blood cell interactions. J Trauma. 2004;57(suppl 1):S7-S12.
13. Pietramaggiori G, Yang HJ, Scherer SS, et al. Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/db mouse. J Trauma. 2008;64:803-808.
14. Fielding CA, McLoughlin RM, McLeod L, et al. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol. 2008;181: 2189-2195.
15. Pietramaggiori G, Scherer SS, Mathews JC, et al. Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen. 2008;16:218-225.
16. Senoo M, Pinto F, Crum CP, et al. p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell. 2007;129:523-536.
17. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999; 398:714-718.
18. Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Sci. 2004;117(pt 20):4619-4628.
19. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341: 738-746.
20. Folkman J, Browder T, Palmblad J. Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost. 2001;86:23-33.
21. Vournakis JN, Eldridge J, Demcheva M, et al. Poly-N-acetyl glucosamine nanofibers regulate endothelial cell movement and angiogenesis: dependency on integrin activation of Ets1. J Vasc Res. 2008;45:222-232.
22. Martin P. Wound healingaiming for perfect skin regeneration. Science. 1997;276:75-81.